Net Income (Quarterly) Chart

View Net Income (Quarterly) for ACET.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Income (Quarterly) Chart
Start Trial

Historical Net Income (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 -21.36M
March 31, 2026 -20.24M
December 31, 2025 -30.52M
September 30, 2025 -26.86M
June 30, 2025 -31.22M
March 31, 2025 -28.21M
December 31, 2024 -28.73M
September 30, 2024 -30.48M
June 30, 2024 -29.90M
March 31, 2024 -28.02M
December 31, 2023 -29.49M
September 30, 2023 -49.88M
June 30, 2023 -32.40M
March 31, 2023 -30.88M
December 31, 2022 -29.88M
September 30, 2022 -22.00M
June 30, 2022 -22.54M
March 31, 2022 4.618M
Date Value
December 31, 2021 -15.81M
September 30, 2021 -14.01M
June 30, 2021 -10.85M
March 31, 2021 -21.32M
December 31, 2020 -8.958M
September 30, 2020 -14.78M
June 30, 2020 -8.455M
March 31, 2020 -4.486M
December 31, 2019 -6.578M
September 30, 2019 -14.78M
June 30, 2019 -18.33M
March 31, 2019 -11.07M
December 31, 2018 -5.757M
September 30, 2018 -8.407M
June 30, 2018 -13.59M
March 31, 2018 -9.859M
December 31, 2017 -23.05M
September 30, 2017 -3.31M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (Quarterly) Range, Past 5 Years

View Net Income (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (Quarterly) Benchmarks

View Net Income (Quarterly) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 31.50M
Alnylam Pharmaceuticals, Inc. 164.49M
Anika Therapeutics, Inc. 3.309M
Savara, Inc. -40.23M
Vericel Corp. 2.206M

Net Income (Quarterly) Related Metrics